Cubilin, a high-density lipoprotein receptor

Current Opinion in Lipidology

Volumn 11, Issue 2, 2000, Pages 133-140

  Moestrup, Søren K ^a   Kozyraki, Renata ^a  

^a AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; CUBILIN; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN RECEPTOR; SCAVENGER RECEPTOR; UNCLASSIFIED DRUG;

CHOLESTEROL METABOLISM; ENDOCYTOSIS; EPITHELIUM; LIVER; PLACENTAL TRANSFER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; REVIEW;

ANIMALS; APOLIPOPROTEIN A-I; CARRIER PROTEINS; HUMANS; KIDNEY; LIGANDS; LIPOPROTEINS, HDL; MODELS, BIOLOGICAL; RATS; RECEPTORS, CELL SURFACE; RECEPTORS, LIPOPROTEIN; RECEPTORS, PEPTIDE; RNA-BINDING PROTEINS; YOLK SAC;

EID: 0034089291     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200004000-00005     Document Type: Review

References (63)

1. 1 Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger M. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci USA 1997; 94:12610-12615.
2. 2 Oram JF, Yokoyama S. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res 1996; 37:2473-2491.
3. 3 Krieger M. Charting the fate of the 'good cholesterol': identification of the high-density lipoprotein receptor SR-BI. Annu Rev Biochem 1999; 68:523-558. A very interesting and detailed review on the comprehensive SR-BI studies carried out.
4. 4 Kozarsky KF, Donahee MH, Rigotti A, Iqbal SN, Edelman ER, Krieger M. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels. Nature 1997; 387:414-417.
5. 5 Gu X, Trigatti B, Xu S, Acton S, Babitt J, Krieger M. The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J Biol Chem 1998; 273:26338-26348.
6. 6 Ji Y, Wang N, Ramakrishnan R, Sehayek E, Huszar D, Breslow JL, Tall AR. Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem 1999; 274:33398-33402. Using transgenic mouse models the authors show that SR-BI also mediates selective uptake of the free cholesterol of HDL.
7. 7 Ji Y, Jian B, Wang N, Sun Y, Moya ML, Phillips MC, et al. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem 1997; 272:20982-20985.
8. 8 Steinberg D. A docking receptor for HDL cholesterol esters. Science 1996; 271:460-461.
9. 9 Llera-Moya M, Rothblat GH, Connelly MA, Kellner-Weibel G, Sakr SW, Phillips MC, Williams DL. Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface. J Lipid Res 1999; 40:575-580. By comparing the closely related receptors SR-BI and CD36, the authors show that SR-BI is more efficient than CD36 in promoting free cholesterol efflux. The possible underlying mechanisms are discussed.
10. 10 Fluiter K, van der Westhuijzen DR, van Berkel TJ. In vivo regulation of scavenger receptor BI and the selective uptake of high density lipoprotein cholesteryl esters in rat liver parenchymal and Kupffer cells. J Biol Chem 1998; 273:8434-8438.
11. 11 Rodrigueza WV, Thuahnai ST, Temel RE, Lund-Katz S, Phillips MC, Williams DL. Mechanism of scavenger receptor class B type I-mediated selective uptake of cholesteryl esters from high density lipoprotein to adrenal cells. J Biol Chem 1999; 274:20344-20350.
12. 12 Fidge NH. High density lipoprotein receptors, binding proteins, and ligands. J Lipid Res 1999; 40:187-201. An interesting and detailed overview of the function of various candidate HDL receptors and HDL binding proteins.
13. 13 Stangl H, Hyatt M, Hobbs HH. Transport of lipids from high and low density lipoproteins via scavenger receptor-BI. J Biol Chem 1999; 274:32692-32698.
14. 14 Swarnakar S, Temel RE, Connelly MA, Azhar S, Williams DL. Scavenger receptor class B, type I, mediates selective uptake of low density lipoprotein cholesteryl ester. J Biol Chem 1999; 274:29733-29739.
15. 15 Williams DL, Connelly MA, Temel RE, Swamakar S, Phillips MC, Llera-Moya M, Rothblat GH. Scavenger receptor BI and cholesterol trafficking. Curr Opin Lipidol 1999; 10:329-339. An interesting review describing the function of SR-BI in relation to HDL- and LDL-cholesterol transport.
16. 16 Glass CK, Pittman RC, Keller GA, Steinberg D. Tissue sites of degradation of apoprotein A-I in the rat. J Biol Chem 1983; 258:7161-7167.
17. 17 Wyne KL, Woollett LA. Transport of maternal LDL and HDL to the fetal membranes and placenta of the golden Syrian hamster is mediated by receptor-dependent and receptor-independent processes. J Lipid Res 1998; 39:518-530. The lipoprotein transport by the hamster placenta, yolk sac and uterine membrane was studied in vivo. In these tissues holoparticle endocytosis of HDL seems to be the main pathway for cholesteryl ester uptake.
18. 18 Glass C, Pittman RC, Civen M, Steinberg D. Uptake of high-density lipoprotein-associated apoprotein A-I and cholesterol esters by 16 tissues of the rat in vivo and by adrenal cells and hepatocytes in vitro. J Biol Chem 1985, 260:744-750.
19. 12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein. Nat Med 1999; 5:656-661. In this paper cubitin is shown to be a high affinity receptor for apolipoprotein AI and to mediate the endocytosis of HDL in yolk sac cells. In-vivo data indicate an important role of renal cubilin in the metabolism of apolipoprotein AI.
20. 20 Hammad SM, Stefansson S, Twal WO, Drake CJ, Fleming P, Remaley A, et al. Cubilin, the endocytic receptor for intrinsic factor-vitamin B12 complex, mediates high-density lipoprotein holoparticle endocytosis. Proc Natl Acad Sci USA 1999; 96:10158-10163. In this paper cubilin is shown to be a receptor for classical endocytosis of HDL in yolk sac cells. Cubilin-mediated uptake of HDL labelled in the protein or the phospholipid component is shown.
21. 12 receptor and target of teratogenic antibodies is a megalin-binding peripheral membrane protein with homology to developmental proteins. J Biol Chem 1998; 273:5235-5242.
22. 12). J Nutr 1999; 129:1761-1764.
23. 12. Banerjee R (editor). New York: John Wiley and Sons, Inc.; 1999. pp. 475-488.
24. 12 receptor, cubilin: molecular characterization and chromosomal mapping of the gene to 10p within the autosomal recessive megaloblastic anemia (MGA1) region. Blood 1998; 91:3593-3600.
25. 12 receptor, cubilin, discloses regions important for membrane association and ligand binding. J Biol Chem 1999; 274:20540-20544. Distinct ligand binding sites are localized in the CUB domain region of cubilin, and the amino-terminal region of cubilin is shown to be important for membrane association of the receptor.
26. 26 Romero A, Romao MJ, Varela PF, Kolln I, Dias JM, Carvalho AL, et al. The crystal structures of two spermadhesins reveal the CUB domain fold. Nat Struct Biol 1997; 4:783-788.
27. 27 Sahali D, Mulliez N, Chatelet F, Laurent-Winter C, Citadelle D, Roux C, et al. Coexpression in humans by kidney and fetal envelopes of a 280 kDa-coated pit-restricted protein. Similarity with the murine target of teratogenic antibodies. Am J Pathol 1992; 140:33-44.
28. 28 Seetharam B, Christensen EI, Moestrup SK, Hammond TG, Verroust PJ. Identification of rat yolk sac target protein of teratogenic antibodies, gp280, as intrinsic factor-cobalamin receptor. J Clin Invest 1997; 99:2317-2322.
29. 29 Christensen EI, Birn H, Verroust P, Moestrup SK. Megalin-mediated endocytosis in renal proximal tubule. Renal Fail 1998; 20:191-199.
30. 30 Gliemann J. Receptors of the low density lipoprotein (LDL) receptor family in man. Multiple functions of the large family members via interaction with complex ligands. Biol Chem 1998; 379:951-964. An exhaustive review of the structure, functions and pathophysiological aspects of the members of the LDL receptor family receptors.
31. 31 Kounnas MZ, Haudenschild CC, Strickland DK, Argraves WS. Immunological localization of glycoprotein 330, low density lipoprotein receptor related protein and 39 kDa receptor associated protein in embryonic mouse tissues. In Vivo 1994; 8:343-351.
32. 32 Zheng G, Bachinsky DR, Stamenkovic I, Strickland DK, Brown D, Andres G, McCluskey RT. Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpa 2MR, and the receptor-associated protein (RAP). J Histochem Cytochem 1994; 42:531-542.
33. 12 proteins. Kräutler B, Arigoni D, Golding BT (editors). Weinheim, Germany: Wiley-VCH; 1998. pp. 461-471.
34. 34 Aminoff M, Carter JE, Chadwick RB, Johnson C, Grasbeck R, Abdelaal MA, et al. Mutations in CUBN, encoding the intrinsic factor-vitamin B12 receptor, cubilin, cause hereditary megaloblastic anaemia 1. Nat Genet 1999; 21:309-313. The first report showing disease-causing mutations in cubilin.
35. 35 Fyfe JC, Ramanujam KS, Ramaswamy K, Patterson DF, Seetharam B. Defective brush-border expression of intrinsic factor-cobalamin receptor in canine inherited intestinal cobalamin malabsorption. J Biol Chem 1991; 266:4489-4494.
36. 36 Xu D, Kozyraki R, Newman TC, Fyfe JC. Genetic evidence of an accessory activity required specifically for cubilin brush-border expression and intrinsic factor-cobalamin absorption. Blood 1999; 94:3604-3606.
37. 37 Sahali D, Mulliez N, Chatelet F, Laurent-Winter C, Citadelle D, Sabourin JC, et al. Comparative immunochemistry and ontogeny of two closely related coated pit proteins. The 280-kd target of teratogenic antibodies and the 330-kd target of nephritogenic antibodies. Am J Pathol 1993; 142:1654-1667.
38. 38 Labeur C, Lambert G, Van Cauteren T, Duverger N, Vanloo B, Chambaz J, et al. Displacement of apo A-I from HDL by apo A-II or its C-terminal helix promotes the formation of pre-beta1 migrating particles and decreases LCAT activation. Atherosclerosis 1998; 139:351-362.
39. 12 and binds receptor-associated protein. J Biol Chem 1997; 272:26497-26504.
40. 40 Batuman V, Verroust PJ, Navar GL, Kaysen JH, Goda FO, Campbell WC, et al. Myeloma light chains are ligands for cubilin (gp280). Am J Physiol 1998; 275:F246-F254.
41. 41 Willnow TE, Goldstein JL, Orth K, Brown MS, Herz J. Low density lipoprotein receptor-related protein and gp330 bind similar ligands, including plasminogen activator-inhibitor complexes and lactoferrin, an inhibitor of chylomicron remnant clearance. J Biol Chem 1992; 267:26172-26180.
42. 2-glycoprotein-I-phospholipid complex harbor a recognition site for the endocytic receptor megalin. J Clin Invest 1998; 102:902-909.
43. 43 Jollie WP. Development, morphology, and function of the yolk-sac placenta of laboratory rodents. Teratology 1990; 41:361-381.
44. 44 Rader DJ, Ikewaki K. Unravelling high density lipoprotein-apolipoprotein metabolism in human mutants and animal models. Curr Opin Lipidol 1996; 7:117-123.
45. 45 Christensen EI, Birn H, Verroust P, Moestrup SK. Megalin-mediated endocytosis in renal proximal tubule. Renal Fail 1998; 20:191-199.
46. 46 Christensen EI, Willnow TE. Essential role of megalin in renal proximal tubule for vitamin homeostasis. J Am Soc Nephrol 1999; 10:2224-2236.
47. 47 Brenner BM, Baylis C, Deen WM. Transport of molecules across renal glomerular capillaries. Physiol Rev 1976; 56:502-534.
48. 48 Braschi S, Neville TA, Vohl MC, Sparks DL. Apolipoprotein A-I charge and conformation regulate the clearance of reconstituted high density lipoprotein in vivo. J Lipid Res 1999; 40:522-532. An important paper showing that charge and conformation of HDL are important parameters for regulation of the rate of clearance of the lipoprotein particle.
49. 49 Bruce C, Chouinard Jr RA, Tall AR. Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr 1998; 18:297-330.
50. 50 Weng W, Brandenburg NA, Zhong S, Halkias J, Wu L, Jiang XC, et al. ApoA-II maintains HDL levels in part by inhibition of hepatic lipase. Studies in apoA-II and hepatic lipase double knockout mice. J Lipid Res 1999; 40:1064-1070. Using apolipoprotein AII and hepatic lipase-deficient mice, the authors demonstrate that apolipoprotein AII is a physiological inhibitor of hepatic lipase and that this is at least a part of the mechanism whereby apolipoprotein AII maintains HDL cholesterol levels.
51. 51 Foger B, Santamarina-Fojo S, Shamburek RD, Parrot CL, Talley GD, Brewer Jr HB. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. J Biol Chem 1997; 272:27393-27400.
52. 52 Lamarche B, Rashid S, Lewis GF. HDL metabolism in hypertriglyceridemic states: an overview. Clin Chim Acta 1999; 286:145-161. An interesting review discussing the HDL catabolism in relation to hypertriglyceridaemia.
53. 53 Jaye M, Lynch KJ, Krawiec J, Marchadier D, Maugeais C, Doan K, et al. A novel endothelial-derived lipase that modulates HDL metabolism. Nat Genet 1999; 21:424-428. This paper reports a third lipase expressed in endothelium. Overexpression of the lipase in mice decreases the level of HDL. The novel lipase is suggested to have an important function in lipoprotein metabolism and vascular biology.
54. 54 De O, Kong M, Han Z, Starr C, Kass EM, Juo SH, et al. Metabolic and genetic determinants of HDL metabolism and hepatic lipase activity in normolipidemic females. J Lipid Res 1999; 40:1211-1221.
55. 55 Levak-Frank S, Weinstock PH, Hayek T, Verdery R, Hofmann W, Ramakrishnan R, et al. Induced mutant mice expressing lipoprotein lipase exclusively in muscle have subnormal triglycerides yet reduced high density lipoprotein cholesterol levels in plasma. J Biol Chem 1997; 272:17182-17190.
56. 56 Ueda Y, Royer L, Gong E, Zhang J, Cooper PN, Francone O, Rubin EM. Lower plasma levels and accelerated clearance of high density lipoprotein (HDL) and non-HDL cholesterol in scavenger receptor class B type I transgenic mice. J Biol Chem 1999; 274:7165-7171. Hepatic overexpression of SR-BI is shown to accelerate the clearance of both HDL- and LDL-cholesterol.
57. 57 Lawn RM, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest 1999; 104:R25-R31. In this paper the authors provide functional data demonstrating that the ABC1 protein regulates cellular cholesterol efflux, which may be important for the size of HDL and thereby HDL clearance. Consistent with similar reports this year from other laboratories, mutations in the ABC1 transporter are shown to be responsible for Tangier disease.
58. 58 Woollett LA. Origin of cholesterol in the fetal golden Syrian hamster: contribution of de novo sterol synthesis and maternal-derived lipoprotein cholesterol. J Lipid Res 1996; 37:1246-1257.
59. 59 Farese Jr RV, Herz J. Cholesterol metabolism and embryogenesis. Trends Genet 1998; 14:115-120.
60. 60 Willnow TE, Hilpert J, Armstrong SA, Rohlmann A, Hammer RE, Burns DK, Herz J. Defective forebrain development in mice lacking gp330/megalin. Proc Natl Acad Sci USA 1996; 93:8460-8464.
61. 61 Sahali D, Mulliez N, Chatelet F, Dupuis R, Ronco P, Verroust P. Characterization of a 280-kD protein restricted to the coated pits of the renal brush border and the epithelial cells of the yolk sac. Teratogenic effect of the specific monoclonal antibodies. J Exp Med 1988; 167:213-218.
62. 62 Roux C, Horvath C, Dupuis R. Teratogenic action and embryo lethality of AY 9944R. Prevention by a hypercholesterolemia-provoking diet. Teratology 1979; 19:35-38.
63. 12 homeostasis. Proc Natl Acad Sci USA 1996; 93:8612-8617.